Medical Properties Trust delivered stable Q1 earnings, maintains a 1.75x dividend coverage, and has a 37% discount to book.

I now believe that HighPeak can deliver slightly above the high-end of its full-year guidance for production. Read why HPK ...

Alibaba leads in AI adoption and merchant productivity enhancements. Click here to read why BABA stock is upgraded to Buy.

VWOB is an emerging market debt index ETF. Click here to read more about VWOB ETF and why it is rated as a Buy.

Terna is accelerating its CapEx, notably on €23B 2024–2028 industrial plan. Read why I believe a more appropriate rating is ...

Enterprise Products Partners boasts low leverage, a hefty yield of 6.88%, and ongoing growth projects. Read why EPD stock is ...

PFO offers little compensation for its higher leverage and risk profile. Read why I see no compelling reason to prefer PFO CEF over better-performing alternatives.

Goldman Sachs has outperformed the S&P 500 and the financial sector. Click here to read why I reiterate my Buy rating for GS ...

Despite decelerating revenue growth, Workday's profitability profile is improving. Read why I recommend WDAY stock a Buy ...

Gladstone Investment's baby bonds, particularly GAINZ and GAINI, offer compelling yields to maturity near 8%. Read more about ...

Fortune Brands Innovations' management is proactively addressing tariff risks and supply chain challenges. Read why soft buy ...

TORM plc delivered solid Q1 results with stabilized freight rates, strong free cash flow, and a $0.40 dividend. Read why TRMD ...